Geneva, Switzerland

Jasna Klicic Badoux


Average Co-Inventor Count = 4.6

ph-index = 1


Company Filing History:


Years Active: 2021-2022

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Jasna Klicic Badoux: Innovator in Blood Disorder Treatments

Introduction

Jasna Klicic Badoux is a prominent inventor based in Geneva, Switzerland. She has made significant contributions to the field of medical science, particularly in the treatment of blood disorders. With a total of 2 patents, her work focuses on innovative compounds that can improve patient outcomes.

Latest Patents

One of her latest patents involves compounds that modulate von Willebrand factor levels and their use in the treatment of blood disorders. This invention relates to a compound having the structure of Formula (I) for use in the prevention or treatment of a blood disorder, particularly by modulating von Willebrand factor levels. Additionally, she has developed a nutraceutical product or food product comprising the compound of the invention. Another significant patent is for heteroaryl SYK inhibitors, which pertains to new substituted heteroaryls of formula 1.

Career Highlights

Throughout her career, Jasna has worked with notable companies such as Société des Produits Nestlé S.A. and Boehringer Ingelheim International GmbH. Her experience in these organizations has allowed her to refine her expertise and contribute to groundbreaking research in her field.

Collaborations

Jasna has collaborated with esteemed colleagues, including Amy Melissa Pooler and Claus Rieker. These partnerships have further enhanced her research and development efforts.

Conclusion

Jasna Klicic Badoux is a trailblazer in the field of blood disorder treatments, with her innovative patents paving the way for future advancements. Her contributions to medical science are invaluable and continue to impact the lives of many.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…